AI assistant
Sending…
BIOLIFE SOLUTIONS INC — Director's Dealing 2020
Nov 17, 2020
32106_dirs_2020-11-16_4474bcfd-0721-45c1-be56-6dd7329c9d4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-11-12
Reporting Person: Schick Joseph C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-12 | Common Stock | M | 5000 | $1.90 | Acquired | 16875 | Direct |
| 2020-11-12 | Common Stock | S | 6250 | $33.12 | Disposed | 10625 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-12 | Stock Option (Right to Buy) | $1.90 | M | 5000 | Disposed | 2026-03-15 | Common Stock (5000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.05 to $33.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2: The options vested 100% on the first anniversary of the grant date.
More from BIOLIFE SOLUTIONS INC
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23